Study participants in our CH-NAT and CH-PAT groups were asymptomatic, had normal neurocognitive testing, normal brain MRI, normal dementia blood workup, and were diagnosed based on CSF Aß42 and Tau measures that were within the published ranges [2], [3]. This evidence concerns the gene MAPT and dementia.